Pancreatic Cancer

Adagrasib induced promising clinical activity as monotherapy among pretreated patients with unresectable or metastatic pancreatic cancer and other gastrointestinal tumors that harbor a KRAS G12C mutation, according to study results.

Adagrasib induced promising clinical activity as monotherapy among pretreated patients with unresectable or metastatic pancreatic cancer and other gastrointestinal tumors that harbor a KRAS G12C mutation, according to study results.

Patients with IgG4-related disease are at a higher risk for cancer — particularly pancreatic and lymphoma — compared with the general population, according to a meta-analysis published in Arthritis Research & Therapy.

Philip A. Philip, MD, PhD, has been appointed director of gastrointestinal oncology and neuroendocrine oncology at Henry Ford Cancer Institute.

Many adults who were diagnosed with cancer said they use dietary supplements because they believe the supplements will help lower their risk for disease recurrence, according to a recent study.

Despite a significant amount of data in the adjuvant setting for pancreatic cancer, more research is needed to better define perioperative and neoadjuvant treatment strategies, according to a speaker at Chemotherapy Foundation Symposium.

Pancreatic cancer often is called the silent killer.

Devimistat plus a modified standard-of-care chemotherapy regimen failed to extend OS among patients with metastatic pancreatic cancer, according to results of the randomized phase 3 AVENGER 500 trial released by the agent’s manufacturer.

Ablative MRI-guided radiation therapy prolonged survival compared with standard therapy among patients with inoperable pancreatic cancer, according to results presented during the European Society for Radiotherapy and Oncology Congress.

Surveillance of patients carrying the CDKN2A gene mutation led to earlier detection of pancreatic ductal adenocarcinoma which improved disease prognosis, according to a presenter at UEG Week.